FDA.reportPublic FDA data

HLA-DR antigen tissue typing IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of one or multiple HLA-DR antigens in a clinical specimen.
GUDID devices
2
Last updated
2020-09-08 08:04:17

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB24390HLA-DRB1 beta chain Control SlidesBIO SB, INC.Control Slides, 5 2020-08-31
B502BSB67990HLA-DR alpha chain Control SlidesBIO SB, INC.Control Slides, 5 2020-08-31